
Sen. Tammy Baldwin @SenatorBaldwin
A big drug company is profiting from an HIV-prevention drug that infringes upon patents owned by the U.S. Government. And they are selling it at a price that makes the drug unaffordable for many Americans. We need answers from @SecAzar about Gilead Sciences. — PolitiTweet.org
The Washington Post @washingtonpost
Gilead defied a government HIV patent. The Justice Department has opened a review. https://t.co/dUx5TUUnpw